Company intelligence / Profile preview
Nuwacell Biotechnologies
- Ownership
- Private
- Development stage
- Phase 1
Overview
Nuwacell has advanced several off-the-shelf, iPSC-derived cell therapy candidates into early-stage clinical trials. Their lead programs include iMSC for knee osteoarthritis in Phase II, genetically modified iMSC for interstitial lung disease in Phase I/II, and iNK-based immunotherapies for hematological malignancies also in Phase I/II. The company is among the first in China to receive IND approval for both iMSC and iNK therapies derived from hiPSCs. No published pivotal efficacy results yet.
- Therapeutic areas
- PulmonologyOncologyImmunologyHematologyRheumatology
- Modalities
- Induced pluripotent stem cells (iPSC)iPSC-derived mesenchymal stromal cells (iMSC)iPSC-derived natural killer cells (iNK)Genetically modified cell therapiesBiological products
- Industry
- Biotech
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Nuwacell Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nuwacell Biotechnologies.